Cargando…
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
In the quest for a formidable weapon against the SARS-CoV-2 pandemic, mRNA therapeutics have stolen the spotlight. mRNA vaccines are a prime example of the benefits of mRNA approaches towards a broad array of clinical entities and druggable targets. Amongst these benefits is the rapid cycle “from de...
Autores principales: | Ouranidis, Andreas, Vavilis, Theofanis, Mandala, Evdokia, Davidopoulou, Christina, Stamoula, Eleni, Markopoulou, Catherine K., Karagianni, Anna, Kachrimanis, Kyriakos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773365/ https://www.ncbi.nlm.nih.gov/pubmed/35052730 http://dx.doi.org/10.3390/biomedicines10010050 |
Ejemplares similares
-
Pharma 4.0 Continuous mRNA Drug Products Manufacturing †
por: Ouranidis, Andreas, et al.
Publicado: (2021) -
Integrating Elastic Tensor and PC-SAFT Modeling with Systems-Based Pharma 4.0 Simulation, to Predict Process Operations and Product Specifications of Ternary Nanocrystalline Suspensions
por: Ouranidis, Andreas, et al.
Publicado: (2021) -
Pharma 4.0-Artificially Intelligent Digital Twins for Solidified Nanosuspensions
por: Davidopoulou, Christina, et al.
Publicado: (2022) -
Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
por: Ouranidis, Andreas, et al.
Publicado: (2020) -
Polyelectrolyte Matrices in the Modulation of Intermolecular Electrostatic Interactions for Amorphous Solid Dispersions: A Comprehensive Review
por: Tsiaxerli, Anastasia, et al.
Publicado: (2021)